The results implied the tumor inhibiting role of CAFs Cav-1 protein and were consistent with the finding in breast and prostate cancer, which elucidated that loss of stromal Cav-1 heralds poor prognosis [8], [12], [15]. The gene discussed is CAV1; the disease is prostate carcinoma.